Showing 1 - 16 results of 16 for search 'Pierre Fenaux', query time: 0.05s
Refine Results
-
1
REFRACTORY THROMBOCYTOPENIA AND NEUTROPENIA: A DIAGNOSTIC CHALLENGE by Emmanuel Gyan, François Dreyfus, Pierre Fenaux
Published 2015-02-01Get full text
Article -
2
TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH HIGH WHITE CELL BLOOD COUNTS. by Lionel Ades, Charicleia Kelaidi, Pierre Fenaux
Published 2011-01-01Get full text
Article -
3
TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH HIGH WHITE CELL BLOOD COUNTS. by Charicleia Kelaidi, Lionel Ades, Pierre Fenaux
Published 2011-09-01Get full text
Article -
4
Arsenic Trioxide Treatment during Pregnancy for Acute Promyelocytic Leukemia in a 22-Year-Old Woman by Claire Cochet, Marion Simonet, Julie Cattin, Jean-Patrick Metz, Ana Berceanu, Eric Deconinck, Etienne Daguindau, Françoise Schillinger, Pierre Fenaux, Nicolas Mottet, Yohan Desbrosses
Published 2020-01-01Get full text
Article -
5
Modeling mesenchymal stromal cell support to hematopoiesis within a novel 3D artificial marrow organoid system by Bérénice Schell, Lin-Pierre Zhao, Inés M’Sibih, Maria Kalogeraki, Camille Kergaravat, Emilie Lereclus, Pierre Fenaux, Lionel Adès, Antoine Toubert, Marion Espéli, Karl Balabanian, Emmanuel Clave, Nicolas Dulphy, Valeria Bisio
Published 2025-07-01Get full text
Article -
6
Very long-term remission with azacitidine in VEXAS syndrome by Lin-Pierre Zhao, Vincent Jachiet, Olivier Kosmider, Lise Larcher, Emmanuelle Clappier, Marie Sébert, Lionel Adès, Pierre Hirsch, Thibault Mahévas, Maxime Battistella, Jean-David Bouaziz, Arsène Mekinian, Pierre Fenaux, MINHEMON FRENVEX
Published 2025-01-01Get full text
Article -
7
Efficacy of erythroid‐stimulating agent and luspatercept in VEXAS syndrome: A multicenter retrospective study by the FRENVEX group by Maël Heiblig, Vincent Jachiet, Jérôme Hadjadj, Lin Pierre Zhao, Thibault Comont, Hervé Lobbes, Valentin Lacombe, Anne Blandine Boutin, Joris Galland, Benjamin Terrier, Sophie Georgin‐Lavialle, Pierre Fenaux, Arsène Mekinian, the FRENVEX Group
Published 2025-06-01Get full text
Article -
8
Psychometric properties and meaningful change thresholds for the QOL-E instrument in patients with myelodysplastic neoplasms by Esther Natalie Oliva, Shien Guo, Jennifer Lord-Bessen, Aylin Yucel, Roberto Latagliata, Massimo Breccia, Giuseppe A. Palumbo, Grazia Sanpaolo, Marta Riva, Valeria Santini, Uwe Platzbecker, Guillermo Garcia-Manero, Pierre Fenaux, Christopher G. Pelligra
Published 2025-02-01Get full text
Article -
9
Prognostic significance of monocytic-like phenotype in patients with AML treated with venetoclax and azacytidine by Lin-Pierre Zhao, Typhaine Dumas-Rivero, Lauren Barette, Lorea Aguinaga, Arij Cheffai, Clémentine Chauvel, Reinaldo Dal Bello, Emmanuel Raffoux, Emmanuelle Clappier, Matthieu Duchmann, Pierre Fenaux, Pierre Lemaire, Stephanie Mathis, Marie Sébert, Lionel Adès, Raphaël Itzykson
Published 2025-07-01Get full text
Article -
10
TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH AIDA BASED REGIMEN by Hela Ben Abid, Zaher Belhadjali, Samia Menif, Naouel Ben Salah, Raihane Ben Lakhal, Lamia Aissaoui, Hend Ben Neji, Zarrouk Mohamed, Kacem Karima, Yosr Ben Abdennebi, Ramzi Ben Amor, Hèla Ghédira, Ramzi Jeddi, Emna Gouider, Raouf Hafsia, Ali Saad, Pierre Fenaux, Balkis Meddeb
Published 2011-01-01Get full text
Article -
11
FLT3 ligand kinetic profile predicts response to treatment in patients with high-risk myelodysplastic syndrome / chronic myelomonocytic leukemia receiving CPX-351: a study from the... by Pierre Peterlin, Joëlle Gaschet, Pascal Turlure, Marie-Pierre Gourin, Pierre-Yves Dumas, Sylvain Thepot, Ana Berceanu, Sophie Park, Marie-Anne Hospital, Thomas Cluzeau, Jose-Miguel Torregrosa-Diaz, Louis Drevon, Rosa Sapena, Fatiha Chermat, Lionel Ades, Sophie Dimicoli-Salazar, Maxime Jullien, Pierre Fenaux, Patrice Chevallier.
Published 2024-11-01Get full text
Article -
12
Infections in lower-risk myelodysplastic syndromes - prevalence and risk factors: a report from the European MDS Registry by Bente Houtman, Adele Taylor, Corine van Marrewijk, Alexandra Smith, Pierre Fenaux, Catherine Cargo, Argiris Symeonidis, Moshe Mittelman, Reinhard Stauder, Jaroslav Čermák, Guillermo Sanz, Eva Hellström-Lindberg, Luca Malcovati, Lionel Adès, Thibault Comont, Dominic Culligan, Ioannis Kotsianidis, Theo de Witte, Nicole Blijlevens, Saskia Langemeijer, Marlijn Hoeks, EUMDS Consortium
Published 2025-04-01Get full text
Article -
13
High levels of global hydroxymethylation predict worse overall survival in MDS patients treated with azacitidine by Francesca Tiso, Florentien E. M. in 't Hout, Ruth Knops, Leonie I. Kroeze, Arno vanRooij, Arjan A. van deLoosdrecht, Theresia M. Westers, Saskia M. C. Langemeijer, Claude Preudhomme, Nicolas Duployez, Pierre Fenaux, Olivier Kosmider, Didier Bouscary, Aniek O. deGraaf, Joost H. A. Martens, Bert A. van derReijden, Lionel Adès, Michaela Fontenay, Joop H. Jansen
Published 2025-01-01Get full text
Article -
14
Long‐term follow‐up and combined Phase 2 results of eprenetapopt and azacitidine in patients with TP53 mutant MDS/AML by David A. Sallman, Rami S. Komrokji, Amy E. Dezern, Marie Sebert, Guillermo Garcia‐Manero, Ramy Rahmé, Eric S. Winer, Jacqueline Lehmann‐Che, Gail J. Roboz, Isabelle Madelaine, Mikkael A. Sekeres, Pierre Peterlin, Onyee Chan, Odile Beyne‐Rauzy, Andrew Kuykendall, Christian Recher, Amy McLemore, Aspasia Stamatoullas, Ling Zhang, Lise Willems, Qianxing Mo, Emmanuel Raffoux, Lisa Nardelli, Céline Berthon, Najla H. Al Ali, Bruno Quesnel, Eric Padron, Hagop M. Kantarjian, Alan F. List, Lionel Ades, Jeffrey E. Lancet, Pierre Fenaux, Thomas Cluzeau
Published 2025-07-01Get full text
Article -
15
Somatic mutations and DNA methylation identify a subgroup of poor prognosis within lower‐risk myelodysplastic syndromes by David Rombaut, Sarah Sandmann, Tobias Tekath, Simon Crouch, Aniek O. deGraaf, Alexandra Smith, Daniel Painter, Olivier Kosmider, Magnus Tobiasson, Andreas Lennartsson, Bert A. van derReijden, Sophie Park, Maud D'Aveni, Borhane Slama, Emmanuelle Clappier, Pierre Fenaux, Lionel Adès, Arjan van deLoosdrecht, Saskia Langemeijer, Argiris Symeonidis, Jaroslav Čermák, Claude Preudhomme, Aleksandar Savic, Ulrich Germing, Reinhard Stauder, David Bowen, Corine vanMarrewijk, Elsa Bernard, Theo deWitte, Julian Varghese, Eva Hellström‐Lindberg, Martin Dugas, Joost Martens, Luca Malcovati, Joop H. Jansen, Michaela Fontenay, MDS‐RIGHT consortium
Published 2025-01-01Get full text
Article -
16
Pivotal results of SELECT-MDS-1 phase 3 study of tamibarotene with azacitidine in newly diagnosed higher-risk MDS by Amy E. DeZern, Sylvain Thepot, Stephane de Botton, Andrea Patriarca, Dries Deeren, Jose-Miguel Torregrossa-Diaz, Giovanni Marconi, Teresa Bernal, Juan Bergua Burgues, Blanca Xicoy, Anna Jonášová, Amer M. Zeidan, Sophie Dimicoli-Salazar, Célestine Simand, David Valcarcel, Maria Diez Campelo, Wanxing Chai-Ho, Lalit Saini, Alice Garnier, Klaus Geissler, Yishai Ofran, Zsolt Nagy, Pramila Krishnamurthy, Michael Lübbert, Grzegorz Basak, Hetty E. Carraway, David A. Sallman, Uma Borate, Valeria Santini, Victoria Campbell, Pierre Fenaux, Thorsten Braun, Francesco Lanza, Jan Maciej Zaucha, David A. Roth, Sofia Paul, Pourab Roy, Michael J. Kelly, Angela Volkert, Jaime Chisholm, Tanya Abdul Malak, Virginia M. Klimek, Thomas Cluzeau
Published 2025-08-01Get full text
Article